Latest filing published 08 Sept 2026 for Autonomix Medical, Inc..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Lori Bisson, listed as finance chief, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Autonomix Medical, Inc. and Soliton, Inc. Over a trading history stretching from 16 December 2021 to 3 September 2026, the count stands at 2 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The latest filing, published on 8 September 2026, reports a share grant in Autonomix Medical, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations